Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: Results of a French multicenter study

Annals of Oncology

Volumn 23, Issue 6, 2012, Pages 1481-1487

  Fauvet, R ^a   Brzakowski, M ^a   Morice, P ^b   Resch, B ^c   Marret, H ^d   Graesslin, O ^e   Darai E ^f  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f HÔPITAL TENON   (France)

Author keywords

Borderline ovarian tumors; Mucinous borderline ovarian tumors; Pregnancy; Restaging surgery; Serous micropapillary borderline ovarian tumors

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN;

ADULT; ARTICLE; BORDERLINE OVARIAN TUMOR; CANCER CENTER; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CYSTECTOMY; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; FRANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MEDICAL RECORD REVIEW; MIXED TUMOR; MUCINOUS CARCINOMA; OVARY TUMOR; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RECURRENT CANCER; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY;

EID: 84861719505     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr452     Document Type: Article

References (34)

1. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971; 50: 1-7.
2. Scully RE. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr 1975; 42: 5-7.
3. Bostwick DG, Tazelaar HD, Ballon SC et al. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer 1986; 58: 2052-2065.
4. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000; 31: 539-557.
5. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer 2006; 42: 149-158.
6. Tavassoli FA, Devilee P. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon, France: IARC Press 2003.
7. International Federation of Gynaecology and Obstetrics. Annual report and results of treatment in gynaecologic cancer. Int J Gynaecol Obstet 1989; 28: 189-190.
8. Bromley B, Benacerraf B. Adnexal masses during pregnancy: accuracy of sonographic diagnosis and outcome. J Ultrasound Med 1997; 16: 447-452.
9. Whitecar MP, Turner S, Higby MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 1999; 181: 19-24.
10. Ueda M, Ueki M. Ovarian tumors associated with pregnancy. Int J Gynaecol Obstet 1996; 55: 59-65.
11. Sherard GB 3rd, Hodson CA, Williams HJ et al. Adnexal masses and pregnancy: a 12-year experience. Am J Obstet Gynecol 2003; 189: 358-362.
12. Desfeux P, Bats AS, Bensaid C et al. Effets de la voie d'abord sur la stadification et la survie des tumeurs ovariennes frontie' res a' un stade pré coce. Gynecol Obstet Fertil 2007; 35: 193-198.
13. Fauvet R, Boccara J, Dufournet C et al. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 2004; 100: 1145-1151.
14. Fauvet R, Boccara J, Dufournet C et al. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005; 16: 403-410.
15. Fauvet R, Poncelet C, Darai E. Faisabilité et limites du traitement coelioscopique des tumeurs frontie' res de l'ovaire. Gynecol Obstet Fertil 2006; 34: 470-478.
16. Darai E, Tulpin L, Prugnolle H et al. Laparoscopic restaging of borderline ovarian tumors. Surg Endosc 2007; 21: 2039-2043.
17. Querleu D, Papageorgiou T, Lambaudie E et al. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours. BJOG 2003; 110: 201-204.
18. Trimble EL, Trimble LC. Epithelial ovarian tumors of low malignant potential. In Markman M, Hoskins WJ (eds), Cancer of the Ovary. New York: Raven Press 1993; 415-429.
19. Yinon Y, Beiner ME, Gotlieb WH et al. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil Steril 2007; 88: 479-484.
20. Laurent I, Uzan C, Gouy S et al. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern. Ann Surg Oncol 2008; 15: 3561-3566.
21. Bell DA, Longacre TA, Prat J et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 2004; 35: 934-948.
22. Shih IM. Ovarian serous low malignant potential (borderline) tumor-does "micropapillary" matter? Gynecol Oncol 2010; 117: 1-3.
23. May T, Virtanen C, Sharma M et al. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol Oncol 2010; 117: 9-17.
24. Silverberg SG, Bell DA, Kurman RJ et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol 2004; 35: 910-917.
25. Longacre TA, Kempson RL, Hendrickson MR. Serous tumours of low malignant potential (serous borderline tumours): moving toward detente. Histopathology 2005; 47: 315-318.
26. Longacre TA, McKenney JK, Tazelaar HD et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol 2005; 29: 707-723.
27. Mooney J, Silva E, Tornos C, Gershenson D. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol Oncol 1997; 65: 30-35.
28. Clinton GM, Hua W. Estrogen action in human ovarian cancer. Crit Rev Oncol Hematol 1997; 25: 1-9.
29. Emons G, Kavanagh JJ. Hormonal interactions in ovarian cancer. Hematol Oncol Clin North Am 1999; 13: 145-161, ix.
30. Garg PP, Kerlikowske K, Subak L, Grady D. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998; 92: 472-479.
31. Rodriguez C, Patel AV, Calle EE et al. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 2001; 285: 1460-1465.
32. Lindgren PR, Cajander S, Backstrom T et al. Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 2004; 221: 97-104.
33. Gerdes J, Lemke H, Baisch H et al. Cell cycle analysis of a cell proliferationassociated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
34. Zapardiel I, Rosenberg P, Peiretti M et al. The role of restaging borderline ovarian tumors: single institution experience and review of the literature. Gynecol Oncol 2010; 119: 274-277.